BioNTech SE (22UA.F)

EUR 90.05

(-1.8%)

Total Assets Summary of BioNTech SE

BioNTech SE's latest annual total assets in 2023 was 23 Billion EUR , down -1.17% from previous year.
BioNTech SE's latest quarterly total assets in 2024 Q1 was 22.27 Billion EUR , down -3.17% from previous quarter.
BioNTech SE reported annual total assets of 23.27 Billion EUR in 2022, up 47.05% from previous year.
BioNTech SE reported annual total assets of 15.83 Billion EUR in 2021, up 582.77% from previous year.
BioNTech SE reported quarterly total assets of 22.25 Billion EUR for 2024 Q2, down -0.12% from previous quarter.
BioNTech SE reported quarterly total assets of 22.2 Billion EUR for 2023 Q3, down -0.08% from previous quarter.

Annual Total Assets Chart of BioNTech SE (2023 - 2016)

Historical Annual Total Assets of BioNTech SE (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	23 Billion EUR	-1.17%
2022	23.27 Billion EUR	47.05%
2021	15.83 Billion EUR	582.77%
2020	2.31 Billion EUR	190.68%
2019	797.64 Million EUR	22.15%
2018	652.98 Million EUR	74.26%
2017	374.71 Million EUR	-3.91%
2016	389.95 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	22.27 Billion EUR	-3.17%
2024 Q2	22.25 Billion EUR	-0.12%
2023 Q3	22.2 Billion EUR	-0.08%
2023 FY	23 Billion EUR	-1.17%
2023 Q2	22.22 Billion EUR	0.66%
2023 Q1	22.07 Billion EUR	-5.16%
2023 Q4	23 Billion EUR	3.6%
2022 Q4	23.27 Billion EUR	2.73%
2022 FY	23.27 Billion EUR	47.05%
2022 Q3	22.66 Billion EUR	7.11%
2022 Q2	21.15 Billion EUR	4.22%
2022 Q1	20.29 Billion EUR	28.23%
2021 Q4	15.83 Billion EUR	11.23%
2021 Q1	4.2 Billion EUR	81.34%
2021 Q3	14.23 Billion EUR	55.57%
2021 Q2	9.14 Billion EUR	117.59%
2021 FY	15.83 Billion EUR	582.77%
2020 Q3	1.44 Billion EUR	48.88%
2020 Q1	732.2 Million EUR	-8.2%
2020 FY	2.31 Billion EUR	190.68%
2020 Q4	2.31 Billion EUR	59.99%
2020 Q2	973.44 Million EUR	32.95%
2019 Q1	- EUR	-100.0%
2019 FY	797.64 Million EUR	22.15%
2019 Q4	797.64 Million EUR	8.02%
2019 Q2	722.36 Million EUR	0.0%
2019 Q3	738.4 Million EUR	2.22%
2018 FY	652.98 Million EUR	74.26%
2018 Q4	652.98 Million EUR	0.0%
2018 Q1	- EUR	0.0%
2017 FY	374.71 Million EUR	-3.91%
2016 FY	389.95 Million EUR	0.0%

Peer Total Assets Comparison of BioNTech SE

Name	Total Assets	Total Assets Difference
CureVac N.V.	788.89 Million EUR	-2816.255%
Biotest Aktiengesellschaft	1.44 Billion EUR	-1492.903%
Biotest Aktiengesellschaft	1.44 Billion EUR	-1492.903%
BRAIN Biotech AG	70.93 Million EUR	-32332.017%
Formycon AG	890.36 Million EUR	-2483.927%
Heidelberg Pharma AG	70.35 Million EUR	-32601.22%
Medigene AG	31.71 Million EUR	-72438.466%